Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990657829> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2990657829 abstract "Introduction: There are no approved therapies for patients with uILD, who may have irreversible ILD. We evaluated efficacy and safety of pirfenidone in patients with progressive fibrosing uILD. Methods: This was a double-blind, randomised, placebo-controlled Phase II trial (NCT03099187). The primary endpoint was predicted FVC change over 24 weeks measured by daily home spirometry; secondary endpoints included changes in FVC (measured at site visits), DLco and 6MWD. Safety was also assessed. Results: 253 patients were randomised and 251 were treated (n=127 pirfenidone; n=124 placebo). Analysis of the primary endpoint was impacted by high intra-individual variability in home spirometry values in both treatment groups, amplified in patients with short observation periods, which prevented application of the planned statistical model. Median (Q1, Q3) FVC change (home spirometry) over 24 weeks was –87.7 mL (–338.1, 148.6) and –157.1 mL (–370.9, 70.1) in pirfenidone and placebo groups, respectively (Table). FVC change measured at site visits considerably favoured pirfenidone over placebo; results for DLco and 6MWD generally trended towards pirfenidone (Table). AE reporting reflected the known safety profile of pirfenidone. Conclusions: The planned statistical model could not be applied to the primary endpoint data. Results of key secondary endpoints suggest patients with progressive fibrosing uILD benefit from pirfenidone." @default.
- W2990657829 created "2019-12-05" @default.
- W2990657829 creator A5006969715 @default.
- W2990657829 creator A5014703126 @default.
- W2990657829 creator A5019246724 @default.
- W2990657829 creator A5028036860 @default.
- W2990657829 creator A5031034216 @default.
- W2990657829 creator A5038098413 @default.
- W2990657829 creator A5044010028 @default.
- W2990657829 creator A5045956987 @default.
- W2990657829 creator A5046825438 @default.
- W2990657829 creator A5050993312 @default.
- W2990657829 creator A5058325633 @default.
- W2990657829 date "2019-09-28" @default.
- W2990657829 modified "2023-10-10" @default.
- W2990657829 title "Late Breaking Abstract - Phase II trial of pirfenidone in patients with progressive fibrosing unclassifiable ILD (uILD)" @default.
- W2990657829 doi "https://doi.org/10.1183/13993003.congress-2019.rct1880" @default.
- W2990657829 hasPublicationYear "2019" @default.
- W2990657829 type Work @default.
- W2990657829 sameAs 2990657829 @default.
- W2990657829 citedByCount "3" @default.
- W2990657829 countsByYear W29906578292020 @default.
- W2990657829 countsByYear W29906578292021 @default.
- W2990657829 crossrefType "proceedings-article" @default.
- W2990657829 hasAuthorship W2990657829A5006969715 @default.
- W2990657829 hasAuthorship W2990657829A5014703126 @default.
- W2990657829 hasAuthorship W2990657829A5019246724 @default.
- W2990657829 hasAuthorship W2990657829A5028036860 @default.
- W2990657829 hasAuthorship W2990657829A5031034216 @default.
- W2990657829 hasAuthorship W2990657829A5038098413 @default.
- W2990657829 hasAuthorship W2990657829A5044010028 @default.
- W2990657829 hasAuthorship W2990657829A5045956987 @default.
- W2990657829 hasAuthorship W2990657829A5046825438 @default.
- W2990657829 hasAuthorship W2990657829A5050993312 @default.
- W2990657829 hasAuthorship W2990657829A5058325633 @default.
- W2990657829 hasConcept C126322002 @default.
- W2990657829 hasConcept C141071460 @default.
- W2990657829 hasConcept C142724271 @default.
- W2990657829 hasConcept C16020263 @default.
- W2990657829 hasConcept C165637977 @default.
- W2990657829 hasConcept C1862650 @default.
- W2990657829 hasConcept C197934379 @default.
- W2990657829 hasConcept C203092338 @default.
- W2990657829 hasConcept C204787440 @default.
- W2990657829 hasConcept C27081682 @default.
- W2990657829 hasConcept C2776042228 @default.
- W2990657829 hasConcept C2777714996 @default.
- W2990657829 hasConcept C2778341716 @default.
- W2990657829 hasConcept C2779832356 @default.
- W2990657829 hasConcept C2780333948 @default.
- W2990657829 hasConcept C3018587741 @default.
- W2990657829 hasConcept C535046627 @default.
- W2990657829 hasConcept C55520419 @default.
- W2990657829 hasConcept C71924100 @default.
- W2990657829 hasConceptScore W2990657829C126322002 @default.
- W2990657829 hasConceptScore W2990657829C141071460 @default.
- W2990657829 hasConceptScore W2990657829C142724271 @default.
- W2990657829 hasConceptScore W2990657829C16020263 @default.
- W2990657829 hasConceptScore W2990657829C165637977 @default.
- W2990657829 hasConceptScore W2990657829C1862650 @default.
- W2990657829 hasConceptScore W2990657829C197934379 @default.
- W2990657829 hasConceptScore W2990657829C203092338 @default.
- W2990657829 hasConceptScore W2990657829C204787440 @default.
- W2990657829 hasConceptScore W2990657829C27081682 @default.
- W2990657829 hasConceptScore W2990657829C2776042228 @default.
- W2990657829 hasConceptScore W2990657829C2777714996 @default.
- W2990657829 hasConceptScore W2990657829C2778341716 @default.
- W2990657829 hasConceptScore W2990657829C2779832356 @default.
- W2990657829 hasConceptScore W2990657829C2780333948 @default.
- W2990657829 hasConceptScore W2990657829C3018587741 @default.
- W2990657829 hasConceptScore W2990657829C535046627 @default.
- W2990657829 hasConceptScore W2990657829C55520419 @default.
- W2990657829 hasConceptScore W2990657829C71924100 @default.
- W2990657829 hasLocation W29906578291 @default.
- W2990657829 hasOpenAccess W2990657829 @default.
- W2990657829 hasPrimaryLocation W29906578291 @default.
- W2990657829 hasRelatedWork W1902974644 @default.
- W2990657829 hasRelatedWork W1909631656 @default.
- W2990657829 hasRelatedWork W2295461102 @default.
- W2990657829 hasRelatedWork W2337223096 @default.
- W2990657829 hasRelatedWork W2411042954 @default.
- W2990657829 hasRelatedWork W2556261113 @default.
- W2990657829 hasRelatedWork W2556745572 @default.
- W2990657829 hasRelatedWork W2556761709 @default.
- W2990657829 hasRelatedWork W2565969277 @default.
- W2990657829 hasRelatedWork W2568153308 @default.
- W2990657829 hasRelatedWork W2571522243 @default.
- W2990657829 hasRelatedWork W2770110095 @default.
- W2990657829 hasRelatedWork W2778567868 @default.
- W2990657829 hasRelatedWork W2944065197 @default.
- W2990657829 hasRelatedWork W2980575734 @default.
- W2990657829 hasRelatedWork W2991303655 @default.
- W2990657829 hasRelatedWork W3093728100 @default.
- W2990657829 hasRelatedWork W3136549768 @default.
- W2990657829 hasRelatedWork W1797499058 @default.
- W2990657829 hasRelatedWork W2108924055 @default.
- W2990657829 isParatext "false" @default.
- W2990657829 isRetracted "false" @default.
- W2990657829 magId "2990657829" @default.
- W2990657829 workType "article" @default.